1. Home
  2. List
Reference Patent

Reference - List

  • 21 Hits
  • Search Condition : Filter (MeSH = Alzheimer Disease* / metabolism)
Species Resource Title
Human and Animal Cells A549 An 11-mer Synthetic Peptide Suppressing Aggregation of Aβ25-35 and Resolving Its Aggregated Form Improves Test Performance in an Aβ25-35-Induced Alzheimer's Mouse Model.
Human and Animal Cells MG6(RCB2403) Enhanced phagocytosis associated with multinucleated microglia via Pyk2 inhibition in an acute β-amyloid infusion model.
Mice RBRC06344 Single-cell multiregion dissection of Alzheimer's disease.
Mice RBRC03390 , RBRC03418 Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport.
Mice RBRC06344 Development of Triphenylmethane Dyes for In Vivo Fluorescence Imaging of Aβ Oligomers.
Mice RBRC06240 Peripheral HMGB1 is linked to O3 pathology of disease-associated astrocytes and amyloid.
C.elegans tm235 baz-2 enhances systemic proteostasis in vivo by regulating acetylcholine metabolism.
Mice RBRC06344 Disturbance in the protein landscape of cochlear perilymph in an Alzheimer's disease mouse model.
DNA material pCAGGS-BLRP-BirA (RDB15774) , pcDNA3.1-SphK2-V5-6His (RDB20442) , pCAGGS-BLRP-hRXRα-IRES-BirA (RDB20443) Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytes.
Human and Animal Cells 201B7-Ff(HPS4290) Astrocyte-targeting therapy rescues cognitive impairment caused by neuroinflammation via the Nrf2 pathway.
Mice RBRC02370 Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase.
Mice RBRC06344 Potential Therapeutic Effects of Bifidobacterium breve MCC1274 on Alzheimer's Disease Pathologies in AppNL-G-F Mice.
Mice RBRC03390 , RBRC03418 , RBRC06344 Apolipoprotein E genotype-dependent accumulation of amyloid β in APP-knock-in mouse model of Alzheimer's disease.
DNA material pCALNL5 (RDB01862) O-GalNAc glycosylation determines intracellular trafficking of APP and Aβ production.
Human and Animal Cells MG6(RCB2403) 3',4'-Dihydroxyflavonol Attenuates Lipopolysaccharide-Induced Neuroinflammatory Responses of Microglial Cells by Suppressing AKT-mTOR and NF-κB Pathways.
Human and Animal Cells 293(RCB1637) , THP-1(RCB1189) Alzheimer's Disease-Associated Alternative Splicing of CD33 Is Regulated by the HNRNPA Family Proteins.
Human and Animal Cells HPS0076 , HPS0360 , HPS3119 , HPS3131 , HPS3410 , HPS3417 , HPS3676 , HPS0254 , HPS0255 , HPS0256 , ... BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer's patients' iPSCs in senescence-related conditions.
Mice RBRC06344 , RBRC03390 , RBRC03418 Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
Mice RBRC06342 Distinct effects of SDC3 and FGFRL1 on selective neurodegeneration in AD and PD.
DNA material pCALNL5 (RDB01862) Endothelial expression of human amyloid precursor protein leads to amyloid β in the blood and induces cerebral amyloid angiopathy in knock-in mice.